ID: ALA3087797

Max Phase: Preclinical

Molecular Formula: C12H19FN2O2S

Molecular Weight: 274.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)CCNS(=O)(=O)c1ccc(F)cc1

Standard InChI:  InChI=1S/C12H19FN2O2S/c1-3-15(4-2)10-9-14-18(16,17)12-7-5-11(13)6-8-12/h5-8,14H,3-4,9-10H2,1-2H3

Standard InChI Key:  NFCCDTZDLXJZOA-UHFFFAOYSA-N

Associated Targets(non-human)

Acetylcholinesterase 1323 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 274.36Molecular Weight (Monoisotopic): 274.1151AlogP: 1.45#Rotatable Bonds: 7
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.76CX Basic pKa: 8.05CX LogP: 1.57CX LogD: 0.93
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.82Np Likeness Score: -2.14

References

1. Andersson CD, Forsgren N, Akfur C, Allgardsson A, Berg L, Engdahl C, Qian W, Ekström F, Linusson A..  (2013)  Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.,  56  (19): [PMID:23984975] [10.1021/jm400990p]

Source